Hepatocyte growth factor induces epithelial cell motility through transactivation of the epidermal growth factor receptor

Experimental Cell Research

Volumn 313, Issue 15, 2007, Pages 3319-3325

  Spix, Julie K ^a   Chay, Edward Y ^a   Block, Ethan R ^a   Klarlund, Jes K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell motility; Cornea; Epidermal growth factor; Hepatocyte growth factor; Transactivation; Wound healing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL MOTILITY; CELL STIMULATION; CONTROLLED STUDY; CORNEA EPITHELIUM; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; KERATINOCYTE; KIDNEY CELL; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSACTIVATION;

EID: 34548028031     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.06.006     Document Type: Article

References (41)

1. Birchmeier C., Birchmeier W., Gherardi E., and Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev., Mol. Cell Biol. 4 (2003) 915-925
2. Boccaccio C., and Comoglio P.M. Invasive growth: a MET-driven genetic programme for cancer and stem cells. Nat. Rev., Cancer 6 (2006) 637-645
3. Matsumoto K., and Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int. J. Cancer 119 (2006) 477-483
4. Conway K., Price P., Harding K.G., and Jiang W.G. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen. 14 (2006) 2-10
5. Christensen J.G., Burrows J., and Salgia R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 225 (2005) 1-26
6. Jiang W.G., Martin T.A., Parr C., Davies G., Matsumoto K., and Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit. Rev. Oncol. Hematol. 53 (2005) 35-69
7. Corso S., Comoglio P.M., and Giordano S. Cancer therapy: can the challenge be MET?. Trends Mol. Med. 11 (2005) 284-292
8. Mazzone M., and Comoglio P.M. The Met pathway: master switch and drug target in cancer progression. FASEB J. 20 (2006) 1611-1621
9. Zieske J.D., Takahashi H., Hutcheon A.E., and Dalbone A.C. Activation of epidermal growth factor receptor during corneal epithelial migration. Investig. Ophthalmol. Vis. Sci. 41 (2000) 1346-1355
10. Block E.R., Matela A.R., SundarRaj N., Iszkula E.R., and Klarlund J. Wounding induces motility in sheets of corneal epithelial cells through loss of spatial constraints: role of heparin-binding epidermal growth factor-like growth factor signaling. J. Biol. Chem. 279 (2004) 24307-24312
11. Xu K.P., Ding Y., Ling J., Dong Z., and Yu F.S. Wound-induced HB-EGF ectodomain shedding and EGFR activation in corneal epithelial cells. Investig. Ophthalmol. Vis. Sci. 45 (2004) 813-820
12. Harris R.C., Chung E., and Coffey R.J. EGF receptor ligands. Exp. Cell Res. 284 (2003) 2-13
13. Fischer O.M., Hart S., Gschwind A., and Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 31 (2003) 1203-1208
14. Ohtsu H., Dempsey P.J., and Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am. J. Physiol.: Cell Physiol. 291 (2006) C1-C10
15. Wilson S.E., He Y.G., Weng J., Zieske J.D., Jester J.V., and Schultz G.S. Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells. Exp. Eye Res. 59 (1994) 665-678
16. Daniels J.T., Limb G.A., Saarialho-Kere U., Murphy G., and Khaw P. Human corneal epithelial cells require MMP-1 for HGF-mediated migration on collagen I. Investig. Ophthalmol. Vis. Sci. 44 (2003) 1048-1055
17. McBain V.A., Forrester J.V., and McCaig C.D. HGF, MAPK, and a small physiological electric field interact during corneal epithelial cell migration. Investig. Ophthalmol. Vis. Sci. 44 (2003) 540-547
18. Mazie A.R., Spix J.K., Block E.R., Achebe H.B., and Klarlund J.K. Epithelial cell motility is triggered by activation of the EGF receptor through phosphatidic acid signaling. J. Cell. Sci. 119 (2006) 1645-1654
19. Gipson I.K., Spurr-Michaud S., Argueso P., Tisdale A., Ng T.F., and Russo C.L. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Investig. Ophthalmol. Vis. Sci. 44 (2003) 2496-2506
20. Jo M., Stolz D.B., Esplen J.E., Dorko K., Michalopoulos G.K., and Strom S.C. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J. Biol. Chem. 275 (2000) 8806-8811
21. Pai R., Nakamura T., Moon W.S., and Tarnawski A.S. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors. FASEB J. 17 (2003) 1640-1647
22. Fischer O.M., Giordano S., Comoglio P.M., and Ullrich A. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J. Biol. Chem. 279 (2004) 28970-28978
23. Aslan M., and Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid. Redox Signal. 5 (2003) 781-788
24. Frank G.D., and Eguchi S. Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin. Antioxid. Redox Signal. 5 (2003) 771-7780
25. Luttrell D.K., and Luttrell L.M. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23 (2004) 7969-7978
26. Lezama R., Diaz-Tellez A., Ramos-Mandujano G., Oropeza L., and Pasantes-Morales H. Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions. Neurochem. Res. 30 (2005) 1589-1597
27. Mossman B.T., Lounsbury K.M., and Reddy S.P. Oxidants and signaling by mitogen-activated protein kinases in lung epithelium. Am. J. Respir.: Cell Mol. Biol. 34 (2006) 666-669
28. Saito Y., Haendeler J., Hojo Y., Yamamoto K., and Berk B.C. Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation. Mol. Cell. Biol. 21 (2001) 6387-6394
29. Nahta R., Yuan L.X., Zhang B., Kobayashi R., and Esteva F.J. Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Res. 65 (2005) 11118-11128
30. Morgillo F., Woo J.K., Kim E.S., Hong W.K., and Lee H.Y. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. Cancer Res. 66 (2006) 10100-10111
31. Johnson G.R., Kannan B., Shoyab M., and Stromberg K. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J. Biol. Chem. 268 (1993) 2924-2931
32. Ridley A.J., Comoglio P.M., and Hall A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15 (1995) 1110-1122
33. Imamura H., Takaishi K., Nakano K., Kodama A., Oishi H., Shiozaki H., Monden M., Sasaki T., and Takai Y. Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells. Mol. Biol. Cell 9 (1998) 2561-2575
34. Liang C.C., and Chen H.C. Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering. J. Biol. Chem. 276 (2001) 21146-21152
35. Singh A.B., Tsukada T., Zent R., and Harris R.C. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells. J. Cell. Sci. 117 (2004) 1365-1379
36. Scheving L.A., Stevenson M.C., Taylormoore J.M., Traxler P., and Russell W.E. Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem. Biophys. Res. Commun. 290 (2002) 197-203
37. Grierson I., Heathcote L., Hiscott P., Hogg P., Briggs M., and Hagan S. Hepatocyte growth factor/scatter factor in the eye. Prog. Retinal Eye Res. 19 (2000) 779-802
38. Klenkler B., and Sheardown H. Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp. Eye Res. 79 (2004) 677-688
39. Sebastian S., Settleman J., Reshkin S., Azzariti J., Bellizzi A., and Paradiso A. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim. Biophys. Acta 1766 (2006) 120-139
40. Citri A., and Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev., Mol. Cell Biol. 7 (2006) 505-516
41. Normanno N., De Luca A., Bianco C., Strizzi L., Mancino M., Maiello M.R., Carotenuto A., De Feo G., Caponigro F., and Salomon D.S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366 (2006) 2-16